C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,274 | 74,603 | 58,809 | 78,157 | 51,293 |
| Marketable Securities | 174,397 | 173,934 | 133,075 | 136,397 | 163,794 |
| Receivables | 2,883 | 2,401 | 6,542 | 2,158 | 8,028 |
| TOTAL | $245,371 | $258,110 | $206,864 | $224,729 | $232,535 |
| Non-Current Assets | |||||
| PPE Net | 4,492 | 4,744 | 5,134 | 5,540 | 5,478 |
| Investments And Advances | 32,600 | 48,563 | 7,875 | 8,419 | 19,619 |
| Other Non-Current Assets | 46,398 | 47,658 | 45,615 | 57,839 | 61,892 |
| TOTAL | $83,490 | $100,965 | $58,624 | $71,798 | $86,989 |
| Total Assets | $328,861 | $359,075 | $265,488 | $296,527 | $319,524 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 773 | 858 | 1,333 | 2,216 | 683 |
| Accrued Expenses | 9,830 | 13,314 | 11,270 | 13,554 | 12,633 |
| TOTAL | $27,249 | $33,032 | $35,945 | $44,456 | $40,820 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,124 | 12,493 | 17,126 | 22,620 | 21,585 |
| Other Non-Current Liabilities | 51,925 | 53,615 | 55,247 | 56,857 | 58,447 |
| TOTAL | $67,365 | $69,456 | $75,135 | $78,007 | $83,564 |
| Total Liabilities | $94,614 | $102,488 | $111,080 | $122,463 | $124,384 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,567 | 97,578 | 96,914 | 71,171 | 71,007 |
| Common Shares | 10 | 9 | 7 | 7 | 7 |
| Retained earnings | -763,822 | -738,693 | -718,207 | -686,041 | -660,021 |
| Other shareholders' equity | -322 | 50 | 87 | -30 | 43 |
| TOTAL | $234,247 | $256,587 | $154,408 | $174,064 | $195,140 |
| Total Liabilities And Equity | $328,861 | $359,075 | $265,488 | $296,527 | $319,524 |